US Stock MarketDetailed Quotes

BLU BELLUS Health

Watchlist
  • 14.740
  • 0.0000.00%
Close Jun 29 09:30 ET
1.87BMarket Cap-20191P/E (TTM)

About BELLUS Health Company

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, a P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.

Company Profile

SymbolBLU
Company NameBELLUS Health
CEOMr. Roberto Bellini
MarketNASDAQ
Employees74
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Websitehttp://www.bellushealth.com

Company Executives

  • Name
  • Position
  • Salary
  • Roberto Bellini
  • Director, President and Chief Executive Officer
  • --
  • Dr. Andreas Orfanos
  • Chief Operating Officer
  • --
  • Dr. Denis Garceau
  • Chief Scientific Officer
  • --
  • Ramzi Benamar
  • Chief Financial Officer
  • --
  • Dr. Catherine Bonuccelli
  • Chief Medical Officer
  • --
  • Tony Matzouranis
  • Senior Vice President, Business Development
  • --
  • Francois Desjardins
  • Senior Vice President, Finance
  • --
  • Dr. Francesco Bellini,PhD
  • Chairman of the Board
  • --
  • William Mezzanotte
  • Director
  • --
  • Pierre Larochelle
  • Lead Independent Director
  • --
  • Dr. Clarissa Desjardins, PhD
  • Independent Director
  • --
  • Youssef L. Bennani
  • Independent Director
  • --
  • Joseph Rus
  • Independent Director
  • --
  • Franklin M. Berger, C.F.A.
  • Independent Director
  • --
  • Sebastien Roy
  • Corporate Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg